(update to news sent on May 25, sale of an additional 10,000 shares has been reported) Henrik Sundin sold 80,000 shares in the research company Hamlet Biopharma, where he is a board member, through the company HS Compliance Partner on May 22 to 25. The shares were sold at an average price of SEK 7.63 per share, a transaction worth SEK 610,100. The transaction was carried out on Spotlight Stock Market. This is stated in the Swedish Financial Supervisory Authority's insider register.HS Compliance Partner then owns 49,954 shares in Hamlet, according to the shareholder service Holdings. Sundin also owns an additional 2.23 million shares in Hamlet in his own name.